MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
Jiangnan Technology Teams Up with SynVista to Launch AI Green Mining Platform
The US Ethereum Spot ETF experiences 5 consecutive days of net inflows ending, with a net outflow of $79 million yesterday.
Suspected Ethena Labs Withdraws Another 25 Million ENA
Yesterday's Whale Trader Who Perfectly Shorted Before the Major Drop Goes Long on ETH with 2x Leverage, Holding a Position Worth $56 Million
Tom Lee: S&P 500 to Rise to 7300, Surge in Market Liquidity Could Be Explosive
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y MM:[email protected]
Programa VIP:[email protected]